Citations (92)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sylvia Romanowska & Michael W Best. (2023) Examining the Role of Failure and Success Experiences on Task Persistence and Neurocognition in Schizophrenia-Spectrum Disorders. Journal of Clinical and Experimental Neuropsychology 45:3, pages 255-269.
Read now
Read now
Thomas Mountjoy, Alastair G. Cardno, Anjula Gupta & Mitch G. Waterman. (2022) To what extent do clinical psychologists working in early psychosis routinely explore trauma with their clients?. Psychosis 0:0, pages 1-14.
Read now
Read now
Articles from other publishers (90)
Kyler Mulhauser, Benjamin M. Hampstead, Lara N. Coughlin & Mark A. Ilgen. (2023) The association between cannabis use and subjective memory complaints in older adults in the United States. Journal of the International Neuropsychological Society 29:9, pages 870-877.
Crossref
Crossref
Chloe A Gott, Matt Thomas, Julaine Allan, Jessica Kennedy, Yvette Black, Frances Dark & Julia M Lappin. (2023) Cognitive remediation therapy – implementation and translation into clinical practice in rural and metropolitan New South Wales mental health services. Australasian Psychiatry 31:5, pages 584-586.
Crossref
Crossref
Carla Morales-Pillado, Belén Fernández-Castilla, Teresa Sánchez-Gutiérrez, Eduardo González-Fraile, Sara Barbeito & Ana Calvo. (2022) Efficacy of technology-based interventions in psychosis: a systematic review and network meta-analysis. Psychological Medicine 53:13, pages 6304-6315.
Crossref
Crossref
Anne-Kari Torgalsbøen, Christine Mohn, Frank Larøi, Susie Fu & Nikolai Czajkowski. (2023) A ten-year longitudinal repeated assessment study of cognitive improvement in patients with first-episode schizophrenia and healthy controls: The Oslo Schizophrenia Recovery (OSR) study. Schizophrenia Research 260, pages 92-98.
Crossref
Crossref
Eric D. Achtyes, Seth C. Hopkins, Nina Dedic, Heather Dworak, Courtney Zeni & Kenneth Koblan. (2023) Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 273:7, pages 1543-1556.
Crossref
Crossref
Pulijala Sulakshana Rao, Madhavi Rangaswamy, Jonathan Evans & Anirban Dutt. (2023) Prospective memory in early and established psychosis: An Indian perspective. Journal of Neuropsychology 17:3, pages 461-476.
Crossref
Crossref
Caroline Gurvich, Natalie Thomas, Abdul-Rahman Hudaib, Tamsyn E. Van Rheenen, Elizabeth H. X. Thomas, Eric J. Tan, Erica Neill, Sean P. Carruthers, Philip J. Sumner, Marco Romano-Silva, Kiymet Bozaoglu, Jayashri Kulkarni & Susan L. Rossell. (2022) The relationship between cognitive clusters and telomere length in bipolar-schizophrenia spectrum disorders. Psychological Medicine 53:11, pages 5119-5126.
Crossref
Crossref
L. Kalisova, J. Michalec, F. Dechterenko, P. Silhan, M. Hyza, M. Chlebovcova, M. Brenova & O. Bezdicek. (2023) Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients. Schizophrenia 9:1.
Crossref
Crossref
Chuanjun Zhuo, Hongjun Tian, Xueqin Song, Deguo Jiang, Guangdong Chen, Ziyao Cai, Jing Ping, Langlang Cheng, Chunhua Zhou & Chunmian Chen. (2023) Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions. Schizophrenia 9:1.
Crossref
Crossref
Rodrigo R. Nieto, Hernán Silva, Alejandra Armijo, Rubén Nachar, Alfonso González, Carmen Paz Castañeda, Cristián Montes & Manuel Kukuljan. (2023) BDNF and Cognitive Function in Chilean Schizophrenic Patients. International Journal of Molecular Sciences 24:13, pages 10569.
Crossref
Crossref
Vineeth Mohan, Pravesh Parekh, Ammu Lukose, Sydney Moirangthem, Jitender Saini, David J. Schretlen & John P. John. (2023) Patterns of Impaired Neurocognitive Performance on the Global Neuropsychological Assessment, and Their Brain Structural Correlates in Recent-onset and Chronic Schizophrenia. Clinical Psychopharmacology and Neuroscience 21:2, pages 340-358.
Crossref
Crossref
Anja Fernqvist, Eirini Alexiou, Henrik Zetterberg, Katarina Howner, Thomas Nilsson & Peter Andiné. (2023) Plasma neurofilament light chain protein is not increased in forensic psychiatric populations: a pilot study. Frontiers in Psychiatry 14.
Crossref
Crossref
Ling-zhuo Kong, Yu-ting Shen, Dan-hua Zhang, Jian-bo Lai & Shao-hua Hu. (2023) Free long-acting injectables for patients with psychosis: A step forward. Asian Journal of Psychiatry 83, pages 103476.
Crossref
Crossref
Chrysoula Zouraraki, Penny Karamaouna & Stella G. Giakoumaki. (2023) Cognitive Processes and Resting-State Functional Neuroimaging Findings in High Schizotypal Individuals and Schizotypal Personality Disorder Patients: A Systematic Review. Brain Sciences 13:4, pages 615.
Crossref
Crossref
Martí Llaurador-Coll, Santiago Rios, Jesus F. García-Gavilán, Nancy Babio, Elisabet Vilella & Jordi Salas-Salvadó. (2023) Plasma levels of neurology-related proteins are associated with cognitive performance in an older population with overweight/obesity and metabolic syndrome. GeroScience.
Crossref
Crossref
Zelin Yuan, Huamin Liu, Xiaochun Zhang, Yong He, Shanyuan Gu, Dan Mo, Shaoli Wang, Zhiwei Huang, Keyi Wu, Rui Zhou, Qi Zhong, Yining Huang, Bifei Cao, Haowen Chen & Xianbo Wu. (2023) Role of uric acid as a biomarker of cognitive function in schizophrenia during maintenance period. Frontiers in Psychiatry 14.
Crossref
Crossref
Faye McKenna, Pradeep Kumar Gupta, Yu Veronica Sui, Hilary Bertisch, Oded Gonen, Donald C Goff & Mariana Lazar. (2023) Microstructural and Microvascular Alterations in Psychotic Spectrum Disorders: A Three-Compartment Intravoxel Incoherent Imaging and Free Water Model. Schizophrenia Bulletin.
Crossref
Crossref
Xinyang Zhang, Xinhu Yang, Zhanming Shi, Rui Xu, Jianqiang Tan, Jianwen Yang, Xiong Huang, Xingbing Huang & Wei Zheng. (2023) A Systematic Review of Intermittent Theta Burst Stimulation for Neurocognitive Dysfunction in Older Adults with Schizophrenia. Journal of Personalized Medicine 13:3, pages 485.
Crossref
Crossref
Navona Calarco, Lindsay D Oliver, Michael Joseph, Colin Hawco, Erin W Dickie, Pamela DeRosse, James M Gold, George Foussias, Miklos Argyelan, Anil K Malhotra, Robert W Buchanan & Aristotle N Voineskos. (2023) Multivariate Associations Among White Matter, Neurocognition, and Social Cognition Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls. Schizophrenia Bulletin.
Crossref
Crossref
Linn Sofie Sæther, Thor Ueland, Beathe Haatveit, Luigi Angelo Maglanoc, Attila Szabo, Srdjan Djurovic, Pål Aukrust, Daniel Roelfs, Christine Mohn, Monica Bettina Elkjaer Greenwood Ormerod, Trine Vik Lagerberg, Nils Eiel Steen, Ingrid Melle, Ole Andreas Andreassen & Torill Ueland. (2022) Inflammation and cognition in severe mental illness: patterns of covariation and subgroups. Molecular Psychiatry 28:3, pages 1284-1292.
Crossref
Crossref
Joana Câmara, Rute Ferreira, Liliana Teixeira, Joana Nóbrega, Carina Romeira, Sergi Bermúdez i Badia & Ana Lúcia Faria. (2021) Efficacy of adaptive cognitive training through desktop virtual reality and paper-and-pencil in the treatment of mental and behavioral disorders. Virtual Reality 27:1, pages 291-306.
Crossref
Crossref
Nadja Tschentscher, Christian F. J. Woll, Julia C. Tafelmaier, Dominik Kriesche, Julia C. Bucher, Rolf R. Engel & Susanne Karch. (2023) Neurocognitive Deficits in First-Episode and Chronic Psychotic Disorders: A Systematic Review from 2009 to 2022. Brain Sciences 13:2, pages 299.
Crossref
Crossref
Ashish Kumar & Arpita Konar. (2023) Editorial: Neuromodulating bioactive compounds as potential cognitive therapeutics. Frontiers in Aging Neuroscience 15.
Crossref
Crossref
Sherry Kit Wa Chan, Yingqi Liao, Christy Lai Ming Hui, Ting Yat Wong, Yinam Suen, Wing Chung Chang, Edwin Ho Ming Lee & Eric Yu Hai Chen. (2023) Longitudinal changes of cognitive function and its relationship with subdomains of negative symptoms in patients with adult-onset first-episode schizophrenia: A 4-year follow up study. Schizophrenia Research 252, pages 181-188.
Crossref
Crossref
Nina Dalkner, Raeanne C. Moore, Colin A. Depp, Robert A. Ackerman, Amy E. Pinkham & Philip D. Harvey. (2023) Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia. Schizophrenia Research 252, pages 1-9.
Crossref
Crossref
Anna Maria Auxilia, Massimiliano Buoli, Alice Caldiroli, Greta Silvia Carnevali, Agnese Tringali, Roberto Nava, Massimo Clerici & Enrico Capuzzi. (2023) High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders. Biomedicines 11:2, pages 314.
Crossref
Crossref
Núria Riera-Molist, Bruna Riera-Morera, Pere Roura-Poch, Josep Manel Santos-López & Quintí Foguet-Boreu. (2023) A Brief Psychoeducation Intervention to Prevent Rehospitalization in Severe Mental Disorder Inpatients. Journal of Nervous & Mental Disease 211:1, pages 40-45.
Crossref
Crossref
Nikita van de Burgt, Willem van Doesum, Mirjam Grevink, Stephanie van Niele, Tom de Koning, Nicole Leibold, Pilar Martinez-Martinez, Therese van Amelsvoort & Danielle Cath. (2023) Psychiatric manifestations of inborn errors of metabolism: A systematic review. Neuroscience & Biobehavioral Reviews 144, pages 104970.
Crossref
Crossref
Hirotaka Sekiguchi, Geoff Pavey & Brian Dean. (2023) Altered levels of dopamine transporter in the frontal pole and the striatum in mood disorders: A postmortem study. Journal of Affective Disorders 320, pages 313-318.
Crossref
Crossref
Runar Elle Smelror & Torill Ueland. 2023. Adolescent Psychosis. Adolescent Psychosis
127
152
.
Emmanuel K. Mwesiga, Andrew S. Ssemata, Joy Gumikiriza, Angel Nanteza, Anne Jacqueline Nakitende, Juliet Nakku, Dickens Akena & Noeline Nakasujja. (2022) The association of cognitive impairment with quality of life and functional impairment in Ugandan first-episode psychosis patients: a cross sectional study. Health and Quality of Life Outcomes 20:1.
Crossref
Crossref
Natalie Frattaroli, Mia Geljic, Dominika Runkowska, Hayley Darke, Caitlin Reddyhough, Taylor Mills, Matthew Mitchell, Rachel Hill, Olivia Carter & Suresh Sundram. (2022) Cognitive and perceptual impairments in schizophrenia extend to other psychotic disorders but not schizotypy. Schizophrenia Research: Cognition 30, pages 100266.
Crossref
Crossref
Huamin Liu, Zhiwei Huang, Xiaochun Zhang, Yong He, Shanyuan Gu, Dan Mo, Shaoli Wang, Zelin Yuan, Yining Huang, Qi Zhong, Rui Zhou, Keyi Wu, Fei Zou & Xianbo Wu. (2022) Association between lipid metabolism and cognitive function in patients with schizophrenia. Frontiers in Psychiatry 13.
Crossref
Crossref
Praveen Goonathilake, Dileepa Ediriweera, Rumi Ruban & Amila Isuru. (2022) Prevalence and correlates of cognitive impairment in schizophrenia: a cross-sectional study from a teaching hospital southern Sri Lanka. BMC Psychiatry 22:1.
Crossref
Crossref
Chuanjun Zhuo, Guangdong Chen, Jiayue Chen, Lei Yang, Qiuyu Zhang, Qianchen Li, Lina Wang, Xiaoyan Ma, Yun Sun, Feng Jia, Hongjun Tian & Deguo Jiang. (2022) Baseline global brain structural and functional alterations at the time of symptom onset can predict subsequent cognitive deterioration in drug-naïve first-episode schizophrenia patients: Evidence from a follow-up study. Frontiers in Psychiatry 13.
Crossref
Crossref
Megan Maroney. (2022) Management of cognitive and negative symptoms in schizophrenia. Mental Health Clinician 12:5, pages 282-299.
Crossref
Crossref
Joseph H. Grotts, Meredith M. Mead, Shayan Rab, Imani J. Walker & Kristen R. Choi. (2022) Geospatial analysis of associations among mental health need, housing need, and involuntary psychiatric hospitalizations of people experiencing homelessness in Los Angeles County. Social Science & Medicine 311, pages 115343.
Crossref
Crossref
Thomas M. Schilling, Vanessa Andelfinger, Magdalena Bossert, Miriam König, Daliah Wolfenson, Sebastian Lang, Gustav Wirtz, Matthias Weisbrod & Steffen Aschenbrenner. (2022) No clinically relevant effects of 12 sessions of 2 mA of anodal transcranial Direct Current Stimulation over the left DLPFC in combination with concurrent cognitive training compared to cognitive training only on executive functions in patients with schizophrenia - A randomized controlled trial. Schizophrenia Research 248, pages 287-289.
Crossref
Crossref
Laura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, Rajiv Radhakrishnan, Ayşegül Yay Pençe, Gamze Erzin, Philippe Delespaul, Gunter Kenis, Jurjen J Luykx, Bochao D Lin, Berna Akdede, Tolga Binbay, Vesile Altınyazar, Berna Yalınçetin, Güvem Gümüş-Akay, Burçin Cihan, Haldun Soygür, Halis Ulaş, Eylem Şahin Cankurtaran, Semra Ulusoy Kaymak, Marina M Mihaljevic, Sanja Andric-Petrovic, Tijana Mirjanic, Miguel Bernardo, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A Saiz, Maria Paz García-Portilla, Julio Sanjuan, Eduardo J Aguilar, José Luis Santos, Estela Jiménez-López, Manuel Arrojo, Angel Carracedo, Gonzalo López, Javier González-Peñas, Mara Parellada, Nadja P Maric, Cem Atbaşoğlu, Alp Üçok, Köksal Alptekin, Meram Can Saka, Eugenio Aguglia, Celso Arango, Bart PF Rutten & Sinan Guloksuz. (2022) The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. European Neuropsychopharmacology 63, pages 47-59.
Crossref
Crossref
Yihe Jiang, Xiujia Sun, Miaowen Hu, Lei Zhang, Nan Zhao, Yifeng Shen, Shunying Yu, Jingjing Huang, Huafang Li & Wenjuan Yu. (2022) Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study. Frontiers in Psychiatry 13.
Crossref
Crossref
Chuanjun Zhuo, Hongjun Tian, Chunhua Zhou, Yun Sun, Xinying Chen, Ranli Li, Jiayue Chen, Lei Yang, Qianchen Li, Qiuyu Zhang, Yong Xu & Xueqin Song. (2022) Transcranial direct current stimulation of the occipital lobes with adjunct lithium attenuates the progression of cognitive impairment in patients with first episode schizophrenia. Frontiers in Psychiatry 13.
Crossref
Crossref
Chuanjun Zhuo, Hongjun Tian, Jiayue Chen, Qianchen Li, Lei Yang, Qiuyu Zhang, Guangdong Chen, Langlang Cheng, Chunhua Zhou & Xueqin Song. (2022) Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes. Frontiers in Genetics 13.
Crossref
Crossref
Sha Liu, Yujie Tong, Xiao Wang, Xin Yu & Yong Xu. (2022) Baseline cognitive functioning can predict the trajectory of acute treatment in first-episode major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience.
Crossref
Crossref
Chuanjun Zhuo, Wei Liu, Ronghuan Jiang, Ranli Li, Haiping Yu, Guangdong Chen, Jianmin Shan, Jingjing Zhu, Ziyao Cai, Chongguang Lin, Langlang Cheng, Yong Xu, Sha Liu, Qinghua Luo, Shili Jin, Chuanxin Liu, Jiayue Chen, Lina Wang, Lei Yang, Qiuyu Zhang, Qianchen Li, Hongjun Tian & Xueqin Song. (2022) Metabolic risk factors of cognitive impairment in young women with major psychiatric disorder. Frontiers in Psychiatry 13.
Crossref
Crossref
Viacheslav TerevnikovGrigori Joffe. (2022) Mirtazapine in schizophrenia – an undeservedly overlooked option?. International Clinical Psychopharmacology 37:4, pages 131-142.
Crossref
Crossref
Álvaro I. Langer, Klaas Wardenaar, Johanna T. W. Wigman, José Luis Ulloa & Daniel Núñez. (2022) A Latent Profile Analysis of Psychotic Experiences, Non-psychotic Symptoms, Suicidal Ideation and Underlying Mechanisms in a Sample of Adolescents From the General Population. Frontiers in Psychiatry 13.
Crossref
Crossref
Guojun Liu, Xiaoying Zhang, Xiaoning Huo & Wei Li. (2022) Prevalence, Influencing Factors, and Clinical Characteristics of Cognitive Impairment in Elderly Patients With Schizophrenia. Frontiers in Psychiatry 13.
Crossref
Crossref
Emmanuel K. Mwesiga, Reuben Robbins, Dickens Akena, Nastassja Koen, Juliet Nakku, Noeline Nakasujja & Dan J. Stein. (2022) Prevalence, profile and associations of cognitive impairment in Ugandan first-episode psychosis patients. Schizophrenia Research: Cognition 28, pages 100234.
Crossref
Crossref
Shayden Bryce, Fran Boyer, Lisa J. Phillips, Emma M. Parrish, Mario Alvarez-Jimenez & Kelly Allott. (2021) Cognitive Strengths in First-Episode Psychosis: Perspectives of Cognition Experts. Journal of Psychosocial Rehabilitation and Mental Health 9:2, pages 177-188.
Crossref
Crossref
Pedro Rocha, Paulina Clara Dagnino, Ronan O’Sullivan, Aureli Soria-Frisch & Constança Paúl. (2022) BRAINCODE for Cognitive Impairment Diagnosis in Older Adults: Designing a Case–Control Pilot Study. International Journal of Environmental Research and Public Health 19:9, pages 5768.
Crossref
Crossref
Bruno Biagianti, Davide Bigoni, Eleonora Maggioni & Paolo Brambilla. (2022) Can neuroimaging-based biomarkers predict response to cognitive remediation in patients with psychosis? A state-of-the-art review. Journal of Affective Disorders 305, pages 196-205.
Crossref
Crossref
Tommy AA Broeders, Alex A Bhogal, Lisan M Morsinkhof, Menno M Schoonheim, Christian H Röder, Mirte Edens, Dennis WJ Klomp, Jannie P Wijnen & Christiaan H Vinkers. (2022) Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning. Journal of Psychopharmacology 36:4, pages 489-497.
Crossref
Crossref
Can Wang, Yue Chong, Jiechun Zhang, Yili Cao & Yanbo Wang. (2022) The Efficacy of Extended Metacognitive Training on Neurocognitive Function in Schizophrenia: A Randomized Controlled Trial. Brain Sciences 12:3, pages 413.
Crossref
Crossref
Katie M. Lavigne, Geneviève Sauvé, Delphine Raucher-Chéné, Synthia Guimond, Tania Lecomte, Christopher R. Bowie, Mahesh Menon, Shalini Lal, Todd S. Woodward, Michael D. Bodnar & Martin Lepage. (2022) Remote cognitive assessment in severe mental illness: a scoping review. Schizophrenia 8:1.
Crossref
Crossref
Mark Ainsley Colijn, Ivan J. Torres, Mahesh Menon, Andrew Howard, William G. Honer & Robert M. Stowe. (2022) Progressive neurocognitive decline in schizophrenia: A diagnostic dilemma for clinicians. Schizophrenia Research 241, pages 59-62.
Crossref
Crossref
Lindsay A. Bornheimer, Derin J. Cobia, Juliann Li Verdugo, Joshua Holzworth & Matthew J. Smith. (2022) Clinical insight and cognitive functioning as mediators in the relationships between symptoms of psychosis, depression, and suicide ideation in first-episode psychosis. Journal of Psychiatric Research 147, pages 85-93.
Crossref
Crossref
Alexandra H Schroeder, Bryce J M Bogie, Tabassum T Rahman, Alexandra Thérond, Hannah Matheson & Synthia Guimond. (2022) Feasibility and Efficacy of Virtual Reality Interventions to Improve Psychosocial Functioning in Psychosis: Systematic Review. JMIR Mental Health 9:2, pages e28502.
Crossref
Crossref
Iain D. Wilkinson, Tariq Mahmood, Sophia Faye Yasmin, Anneka Tomlinson, Jamshid Nazari, Hamid Alhaj, Soumaya Nasser el din, Joanna Neill, Chhaya Pandit, Shahzad Ashraf, Alastair G. Cardno, Steven J. Clapcote, Chris F. Inglehearn & Peter W. Woodruff. (2022) In memory of Professor Iain Wilkinson: cognitive and neuroimaging endophenotypes in a consanguineous schizophrenia multiplex family. Psychological Medicine, pages 1-9.
Crossref
Crossref
Maryse Badan Bâ, Logos Curtis & Giuseppe Pellizzer. (2022) Viewer and object mental rotation in young adults with psychotic disorders. Schizophrenia Research 240, pages 92-102.
Crossref
Crossref
Estela Jiménez-López, Clara María Villanueva-Romero, Eva María Sánchez-Morla, Vicente Martínez-Vizcaíno, M. Ortiz, Roberto Rodriguez-Jimenez, Eduard Vieta & José Luis Santos. (2022) Neurocognition, functional outcome, and quality of life in remitted and non-remitted schizophrenia: A comparison with euthymic bipolar I disorder and a control group.. Schizophrenia Research 240, pages 81-91.
Crossref
Crossref
Kristina M. Gicas, Puneet K. Parmar, Giulia F. Fabiano & Farzaneh Mashhadi. (2022) Substance-induced psychosis and cognitive functioning: A systematic review. Psychiatry Research 308, pages 114361.
Crossref
Crossref
Matthew C. Johnson, Aakash Sathappan, John G. Hanly, Gail S. Ross, Aaron J. Hauptman, William S. Stone & Kevin M. Simon. (2022) From the Blood-Brain Barrier to Childhood Development: A Case of Acute-Onset Psychosis and Cognitive Impairment Attributed to Systemic Lupus Erythematosus in an Adolescent Female. Harvard Review of Psychiatry 30:1, pages 71-82.
Crossref
Crossref
Jessica A. Davis, Hajara Aslam, Felice N. Jacka & Wolfgang Marx. 2022. Diet, Inflammation, and Health. Diet, Inflammation, and Health
531
563
.
Kirsten Catthoor & Geert Dom. 2022. Psychosis and Personality Disorders. Psychosis and Personality Disorders
57
73
.
Stefano Barlati, Cassandra Ariu, Andrea Garozzo & Antonio Vita. 2022. Psychosis and Personality Disorders. Psychosis and Personality Disorders
19
56
.
Nicole R. Karcher, Jaisal Merchant, Jacob Pine & Can Misel Kilciksiz. 2023. Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework. Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework
173
203
.
Maria Beatrice Zazzara, Davide Liborio Vetrano, Angelo Carfì, Rosa Liperoti, Cecilia Damiano & Graziano Onder. (2022) Comorbidity patterns in institutionalized older adults affected by dementia. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14:1.
Crossref
Crossref
Nina Dedic, Heather Dworak, Courtney Zeni, Grazia Rutigliano & Oliver D. Howes. (2021) Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies. International Journal of Molecular Sciences 22:24, pages 13185.
Crossref
Crossref
C. Vinkers, T. Broeders, A. Bhogal, L. Morsinkhof, M. Schoonheim, C. Roder, M. Edens, D. KLomp & J. Wijnen. (2021) P.0186 Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation with cognitive functioning. European Neuropsychopharmacology 53, pages S134-S135.
Crossref
Crossref
Diann E. Gaalema, Katharine Mahoney & Jacob S. Ballon. (2021) Cognition and Exercise. Journal of Cardiopulmonary Rehabilitation and Prevention 41:6, pages 400-406.
Crossref
Crossref
James Neef & Daniel S. Palacios. (2021) Progress in mechanistically novel treatments for schizophrenia. RSC Medicinal Chemistry 12:9, pages 1459-1475.
Crossref
Crossref
Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal, Araba Chintoh & Ofer Agid. (2021) Schizophrenia: Antipsychotics and drug development. Behavioural Brain Research 414, pages 113507.
Crossref
Crossref
G. Horvath, G. Kis, G. Kekesi, A. Büki, L. G. Adlan, E. Szűcs, H. El Heni & S. Benyhe. (2021) Interaction of clozapine with metformin in a schizophrenia rat model. Scientific Reports 11:1.
Crossref
Crossref
Luis Gutiérrez-Rojas, Pablo Jose González-Domenech, Gema Junquera, Tate F. Halverson & Guillermo Lahera. (2021) Functioning and Happiness in People with Schizophrenia: Analyzing the Role of Cognitive Impairment. International Journal of Environmental Research and Public Health 18:14, pages 7706.
Crossref
Crossref
Thomas M. Schilling, Magdalena Bossert, Miriam König, Gustav Wirtz, Matthias Weisbrod & Steffen Aschenbrenner. (2021) Acute effects of a single dose of 2 mA of anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex on executive functions in patients with schizophrenia—A randomized controlled trial. PLOS ONE 16:7, pages e0254695.
Crossref
Crossref
Daniel Núñez, Jorge L. Ordóñez-Carrasco, Reiner Fuentes & Álvaro I. Langer. (2021) Experiential avoidance mediates the association between paranoid ideation and depressive symptoms in a sample from the general population. Journal of Psychiatric Research 139, pages 120-124.
Crossref
Crossref
Wolfgang Marx, David R. Skvarc, Mohammadreza Mohebbi, Adam J. Walker, Alcy Meehan, Alyna Turner, Andrea Baker, Seetal Dodd, Sue M. Cotton, James Graham Scott, Bianca E. Kavanagh, Melanie M. Ashton, Ellie Brown, John J. McGrath, Michael Berk & Olivia May Dean. (2021) The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial. Frontiers in Psychiatry 12.
Crossref
Crossref
Felix Richter, Dagmar Steinmair & Henriette Löffler-Stastka. (2021) Construct Validity of the Mentalization Scale (MentS) Within a Mixed Psychiatric Sample. Frontiers in Psychology 12.
Crossref
Crossref
F. Markus Leweke, Cathrin Rohleder, Christoph W. Gerth, Martin Hellmich, Ralf Pukrop & Dagmar Koethe. (2021) Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial. Frontiers in Pharmacology 12.
Crossref
Crossref
Mary Birken, Hei Ting Wong, Peter McPherson & Helen Killaspy. (2020) A systematic review of the published literature on interventions to improve personal self-care for people with severe mental health problems. British Journal of Occupational Therapy 84:4, pages 200-211.
Crossref
Crossref
T. Jordan Walter, Nina Pocuca, Jared W. Young, Mark A. Geyer, Arpi Minassian & William Perry. (2021) The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review. Psychiatry Research 297, pages 113695.
Crossref
Crossref
Penny Karamaouna, Chrysoula Zouraraki & Stella G. Giakoumaki. (2021) Cognitive Functioning and Schizotypy: A Four-Years Study. Frontiers in Psychiatry 11.
Crossref
Crossref
Raquel Simões de Almeida. 2021. Handbook of Research on Solving Modern Healthcare Challenges With Gamification. Handbook of Research on Solving Modern Healthcare Challenges With Gamification
186
204
.
Steffen Moritz, Steven M Silverstein, Thomas Beblo, Zeynep Özaslan, Mathias Zink & Jürgen Gallinat. (2021) Much of the Neurocognitive Impairment in Schizophrenia is Due to Factors Other Than Schizophrenia Itself: Implications for Research and Treatment. Schizophrenia Bulletin Open 2:1.
Crossref
Crossref
Robert Göder, Sarah Bares, Charlotte Vogel, Heidi Böttcher, Henning Johannes Drews, Julia Lechinger, Kamila Jauch-Chara & Sara Weinhold. (2021) Psychotic-like experiences in patients with insomnia or sleep apnea: associations with sleep parameters. Sleep Medicine 77, pages 367-373.
Crossref
Crossref
Huiru Cui, Anthony J. Giuliano, Tianhong Zhang, Lihua Xu, Yanyan Wei, Yingying Tang, Zhenying Qian, Lena M. Stone, Huijun Li, Susan Whitfield-Gabrieli, Margaret Niznikiewicz, Matcheri S. Keshavan, Martha E. Shenton, Jijun Wang & William S. Stone. (2020) Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes. Schizophrenia Research 226, pages 138-146.
Crossref
Crossref
Francesco Dal Santo, Leticia González-Blanco, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Ángela Velasco, Clara María Álvarez-Vázquez, Clara Martínez-Cao, Pilar A. Sáiz, María Paz García-Portilla & Julio Bobes. (2020) Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences. Scientific Reports 10:1.
Crossref
Crossref
Stefan Jerotic, Zora Ignjatovic, Steven M. Silverstein & Nadja P. Maric. (2020) Structural imaging of the retina in psychosis spectrum disorders: current status and perspectives. Current Opinion in Psychiatry 33:5, pages 476-483.
Crossref
Crossref
Gary Remington & Shitij Kapur. (2020) Antipsychotics Circa 2020: What are we thinking?. Neuropharmacology 175, pages 108181.
Crossref
Crossref
Francesco Dal Santo, Isaac Jarratt-Barnham, Leticia González-Blanco, María Paz García-Portilla, Julio Bobes & Emilio Fernández-Egea. (2020) Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model. European Neuropsychopharmacology 33, pages 158-163.
Crossref
Crossref